Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Addiction. 2010 May 14;105(7):1226–1234. doi: 10.1111/j.1360-0443.2010.02947.x

Table 3.

Multi-level analysis of average medical costs (including psychiatric services and AOD treatment costs)

Fixed Effect Co-efficient Standard Error P-value
Intercept* (π0) Intercept (β00 = γ000) 66.14 9.45 < .01
Age group (β01 = γ010)
(Reference group: Age <=18)
49.65 10.98 < .01
Pre-Intake Cost* (β02 = γ020) 0.37 0.04 < .01
Year (Slope)*(π1) Intercept (β10)
Intercept (γ100) -4.98 4.10 0.22
Family member of non-abstinent AOD patient (γ101) 11.75 4.80 0.01
Family member of abstinent AOD patient (γ102)
(Reference group: Control family member)
7.49 3.67 0.04
Age group (β11 = γ 110)
(Reference group: Age <=18)
15.29 6.13 0.01
Random Effects Variance Componen t Degrees of Freedom P-value
Level-1 (Temporal) Variance 402.40
Level-2 (Individual within families) Variance
Initial Status 385.87 4552 0.00
Slope 238.16 8158 0.00
Level-3 (between families) Variance 0.44 3605 0.00